Curriculum Vitae s397

CURRICULUM VITAE

Name : Rasha Mohamed Moustafa Haggag

Address: Medical Oncology Department , Faculty of Medicine, Zagagzig University, Zagazig, Sharkia , Egypt.

E-mail: [email protected] [email protected]

PERSONAL DATA

Date of October 6, 1974 Birth:

Citizenship: Egyptian.

CURRENT POSITION

October , 2015 – till Associate professor medical oncology present : Department Zagazig University, Egypt.

PREGRADUATE MEDICAL EDUCATION

December 1998: M.B.B.CH., Faculty of Medicine, Zagazig University, Egypt. Total grade; Very good with honor.

POSTGRADUATE MEDICAL QUALIFICATIONS

December 2015: ESMO-MORA Recertification 2015-2020

October 2010: European Certification in Medical Oncology (ESMO exam, 2010).

May 2010: M. D. Medical Oncology, National Cancer Institute, Cairo University, Egypt.

May 2004: M.Sc. in Internal Medicine, Faculty of Medicine, Zagazig University, Egypt. Total grade; Very good.

POSTGRADUATE MEDICAL TRAINING

August, 2004 – May, 2010:

May, 2003- August, 2004:

August, 2000 - April, 2003: March, 2000 - August, 2000:

March, 1999- February, 2000:

POSTGRADUATE ACADEMIC TRAINING

October, 2006: November, 2006:

November, 2006:

May, 2007:

June, 2007:

June – July, 2009:

November , 2012:

CONFERENCES ATTENDANCE

November, 2005: Educational course on genitourinary cancer. European Society of Medical Oncology in collaboration with National Cancer Institute, Cairo University. April, 2007 : The American Society Of Clinical Oncology Multidisciplinary Cancer Management course in collaboration with South and Mediterranean college of oncology, Egypt. May, 2008: The 8th annual conference of diabetes and endocrine unit, on the theme of: a better life for diabetes focus on, neuro- endocrinology. Zagazig university. nd January, 2010 : The 2 Breast- Gynecological International Cancer Conference BGICC 2010 CAIRO, Egypt. September, 2010: 19th Annual Conference Individualized Cancer Management Cairo, Egypt October, 2010: Joint International Conference of NCI Egypt, EORTC and MMOF (Lung and Breast). Cairo, Egypt.

September, 2011: European Multidisciplinary Cancer Congress, Stockholm, Sweden. November, 2011: Eastern Mediterranean Blood and marrow transplantation (EMBMT) GROUP, Dubai, United Arab Emirates. January, 2012: Expanding Treatment Options for Thoracic Malignancy Past, Present and Future, Kuwait.

October, 2012: 15th Annual International Scientific Conference Of Alexandria Clinical Oncology Department. Cancer Management: Options And Promising Directions. Alexandria, Egypt. May – june 2013 2013 ASCO Annual Meeting.

April, 2014 THE Christie- Egyptian Hemato-Oncology Symposium, Manchester, United Kingdom. March, 2015 Renal Horizons, Athens, Greece, Case study presentation.

CREDIT HOURS

May, 2009: 9th Pan-Arab Cancer Congress, Cairo, Egypt. (12 CME hours). The 3rd international BREAST CANCER October, 2011: CONFERENCE. JEDDAH, KSA.(21CME hours). The 6th Middle East Best of CTRC-ACCR San Antonio January, 2012: Breast Cancer, Conference, Jeddah, KSA.(23 CME hours).

COOPERATIVE CLINICAL TRIALS

June, 2001 – November, Study of serum vascular endothelial growth factor and 2003 vascular cell adhesion molecule in metastatic breast cancer and response to weekly docetaxel. Jan, 2005- Nov, 2009 Impact of molecular prognostic factors in advanced bladder cancer patients receiving chemotherapy.

Feb, 2014- ongoing : Middle East &North Africa Registry to characterize Rate of Ras mutation status in newly diagnosed patients with mCRC (MORE-RAS).

F. Abu-Taleb, Ibraheem Amin, Saad Elesh, R. Haggag: Study of vascular endothelial growth factor (VEGF) and vascular cell adhesion molecule-1(VCAM- 1)in metastatic breast cancer (MBC) and response to weekly docetaxel protocol.16th ICACT , Feb. 1th -4th 2005, Paris, France.

H. M. Khaled, F. Abu-Taleb, A. Zekri, R. Haggag (2010): Gene expression profile of advanced squamous and transitional cell carcinoma of the bladder. ASCO annual meeting. Vol (28), No 15S, part I, page: 359s, (abstract: 5472).

H. Khaled, F. Abu-Taleb, R. Haggag and A. Zekri (2011): Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial. Journal of Clinical Oncology, 2011 Genitourinary Cancers Symposium. Vol (29), No 7_suppl (March 1 Supplement), 2011: 266. Mona A. El-Hariri, Ghada K. Gouhar, Rasha M. Haggag (2011): Whole-body FSE STIR MR imaging of lymphoma. The Egyptian Journal of Radiology and Nuclear Medicine (2011): 42, 77–85.

Abdullah S. Al-Zahrani, Amr T. El-Kashif, Rasha M. Haggag, and Samy A. Alsirafy (2012): Pattern of Cancer Deaths in a Saudi Tertiary Care Hospital. American Journal of Hospice& Palliative Medicine. , 1049909112437574, first published on February 28.

Rasha Mohamed Haggag, Kamel Farag, Fouad Abu-Taleb, Sameh Shamaa, Abdel- Rahman Zekri, Tarek ELBolkainy, Hussein Mustafa Khaled (2013);Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial: An update. J Clin Oncol 31, 2013 (suppl; abstr 4537), poster presentation.

R. Haggag and F. AbuTaleb. (2013): The outcome of acute myeloid leukemia presenting with leucopenia: A retrospective study. UAE CANCER CONGRESS 2013 (POSTER PRESENTATION).

S. Elsamany, A. Alzahrani, M. Mahroos, A. Elnagar, R. Haggag, H. El Taani: Clinico-pathological pattern of colorectal cancer in young patients,western Saudi Arabia experience. Asia-Pacific Gastroenterology Cancer Summit 2013. poster presentation.

Rasha Haggag, Kamel Farag, Fouad Abu-Taleb, Sameh Shamaa, Abdel-Rahman Zekri, Tarek ELBolkainy, Hussein Khaled: Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial—an update. Medical Oncology, December 2013, 31:811. http://dx.doi.org/10.1007/s12032-013-0811- 5. Shereef Elsamany, Abdullah Saeed Alzahrani, Mervat Mahrous, Soha Elmorsy, Jamal M Zekri, Ahmed Alshehri, Rasha Mohamed Haggag, Ahmed Abdel Raheem Ahmed, Hani A. El Taani (2014); Clinicopathologic patterns and survival outcome of colorectal cancer in young patients: Western Saudi Arabia experience. J Clin Oncol 32, 2014 (suppl; abstr e14629).

Fouad Abu-Taleb, Rasha Haggag, Yasser Elnaggar, and Ahmed Embaby: Impact of Immunochemotherapy-Related Hepatic Toxicity on the Outcome of HCV-Positive Diffuse Large B-Cell Lymphoma Patients. Journal of Cancer ResearchVolume 2014 (2014), Article ID 982080. http://dx.doi.org/10.1155/2014/982080. Elsamany SA , Alzahrani AS, Mohamed MM, Elmorsy SA, Zekri JE, Al- Shehri AS, Haggag RM, Alnagar AA, El Taani HA. Clinico-pathological patterns and survival outcome of colorectal cancer in young patients: western Saudi Arabia experience. Asian Pac J Cancer Prev. 2014; 15(13):5239-43. Rasha Haggag , Jamal Zekri, Kamel Farag : Assessment of initial real life experience with Abiraterone Acetate in patients with castrate resistant prostate cancer: A retrospective study in Saudi Arabian patients. ASUCOC 2014 (poster presentation) (Abstract#3). Rasha Haggag, Ahmad Zahran, Fouad Abou-Taleb: Clinicopathological features of breast cancer molecular subtypes in Egyptian women reside at Sharkia governorate. ASUCOC 2014 (poster presentation) (Abstract#5). Rasha Haggag, Ola Hussein, Hanaa Abd El Moaty, Alaa Omran, Hoda Ebian. Study Of Plasma Endostatin Level In Patients With Acute Myeloid Leukemia. EHA20, e-poster display, (abstract#E925). Mona Hassanein, Rasha Haggag Shereen El Shorbagy, Hoda F.Ebian. Prognostic value of Hematogones in patients with acute myeloid leukemia in first complete remission. EHA20, abstract publications, (abstract # PB1635). Zekri AR1, Hassan ZK, Bahnassy AA, Khaled HM, El-Rouby MN, Haggag RM, Abu-Taleb FM. Differentially expressed genes in metastatic advanced egyptian bladder cancer. Asian Pac J Cancer Prev. 2015; 16(8):3543-9. Hany A Labiband, Rasha Haggag. CD4+CD25+high FoxP3 regulatory T-Cells in typical and atypical Philadelphia +ve CML as regard response to Imatinib therapy. J Am Sci 2015;11(5):34- 41]. (ISSN: 1545-1003).http://www.jofamericanscience.org. Shereen El Shorbagy, Rasha Haggag, Hoda F.Ebian. Prognostic impact of 25- hydroxyvitamin D levels in Egyptian patients with breast cancer. ABC3-Advanced Breast Cancer Third International Consensus Conference 2015. abstract publications, (abstract # PR150). Rasha Haggag, Jamal Zekri, Kamel Farag (2015); Assessment of initial real life experience with Abiraterone Acetate in patients with castrate resistant prostate cancer: A retrospective study in Saudi Arabian patients Int. J. of Adv. Res. 3 (6). 940-946] (ISSN 2320-5407). www.journalijar. Hussein Khaled Hamdy Abdel Azim Emad Barsoum George Chahine Ali Shamseddine Gamal Abdel Metaal Abbas Omar Abdul Rahman Jazeih Rasha Haggag Atef Badran. A multicenter, phase II study of the RAF-kinase inhibitor sorafenib in patients with advanced renal cell carcinoma. MOLECULAR AND CLINICAL ONCOLOGY. 3, pages: 1099-1102, 2015 DOI: 10.3892/mco.2015.603.

Samy A. Alsirafy , Dina E. Farag , Mostafa S. El-Haddad2, Rasha Haggag, Omar O. Zaki , Noha Y. Ibrahim, Ahmad M. Hammad1Do Egyptian patients know their diagnosis of cancer?. The European Cancer Congress 2015 (ECCO) Poster presentation . http://www.europeancancercongress.org/Scientific-Programme/Searchable- Programme#anchorScpr.

Thoraya Abdel Hamid, Hossam Mahmoud, Fouad Abu- Taleb, Asmaa Mahmoud, Asmaa Salama, Rasha Haggag, Hussein Khaled. Response to two treatment regimens in adult Egyptian patients with Burkitt’s lymphoma. The European Cancer Congress 2015 (ECCO) Poster presentation. http://www.europeancancercongress.org/Scientific-Programme/Searchable- Programme#anchorScpr.

Shereen El Shorbagy , Rasha Haggag, Nashwa Alazizi, Tarek Abouzeid. CD56 and CD19 Antigens Expression in Acute Myeloid Leukemia. International Journal of Science and Research (IJSR). 2016, 5(1):523 ·

Mona Hassanein · Rasha Haggag · Shereen M. El Shorbagy · Hoda F. Ebian. Prognostic Value of Hematogones in Patients with Acute Myeloid Leukemia in First Complete Remission. Blood Disord Transfus 2015, 6: 6.

MEMBERSHIPS

Certified European Society for Medical Oncology (ESMO) member, ESMO 2010. American Society of Clinical Oncology member. Zagazig University Institutional Review Board member. Breast gynecological cancer group. Egyptian hematology oncology group. NON-MEDICAL LICENSE

Test of English as a Foreign Language (TOEFL).

NON-MEDICAL SKILLS

Fluent English Excellent command of Microsoft Office.

Sincerely, Rasha M. Haggag